B
Ecosystem Profile
Biossil Inc.
Biotech startup that uses an AI platform to identify and develop discarded drug molecules for new therapies.
Canadian Venture (ON)2
Dispatches
Apr 25, 2026
Last Signal
Full Coverage Archive
Biossil Repurposes Failed Drug Candidates Using Advanced AI Platform
Tech SignalApr 25, 20262 min
Biossil Repurposes Failed Drug Candidates Using Advanced AI Platform
The challenge of drug discovery has historically been defined by attrition. A molecule can show immense promise, only to fall through the rigorous gauntlet of preclinical and early clinical testing for reasons...
Read article
Biossil Rethinks Drug Development: Mapping Therapeutics Through Semantic Vectors
Biossil Rethinks Drug Development: Mapping Therapeutics Through Semantic Vectors
The core strength of Biossil Inc. lies not in molecular engineering, but in its sophisticated application of natural language processing (NLP) to solve a systemic problem: the massive loss of therapeutic value...
Read article